---
title: "Novo Nordisk's oral semaglutide has been approved by the European Union for the treatment of reducin"
description: "Novo Nordisk's oral semaglutide has been approved by the European Union for the treatment of reducing the risk of cardiovascular death, heart attack, and stroke"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/257366889.md"
published_at: "2025-09-15T12:09:16.000Z"
---

# Novo Nordisk's oral semaglutide has been approved by the European Union for the treatment of reducin

> Novo Nordisk's oral semaglutide has been approved by the European Union for the treatment of reducing the risk of cardiovascular death, heart attack, and stroke

Novo Nordisk's oral semaglutide has been approved by the European Union for the treatment of reducing the risk of cardiovascular death, heart attack, and stroke

### Related Stocks

- [NVO.US - Novo Nordisk AS](https://longbridge.com/en/quote/NVO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Novo Nordisk CFO Karsten Munk Knudsen Sells Shares Worth Over DKK 8.3 Million | Novo Nordisk A/S announced that CFO Karsten Munk Knudsen sold 26,246 shares for DKK 8.3 million at DKK 315.60 each and 3 | [Link](https://longbridge.com/en/news/275652909.md) |
| Berenberg Bank Reaffirms Their Buy Rating on Novo Nordisk (0QIU) | Berenberg Bank analyst Kerry Holford has reaffirmed a Buy rating on Novo Nordisk (0QIU) with a price target of DKK360.00 | [Link](https://longbridge.com/en/news/275719942.md) |
| Novo Nordisk to Manufacture Wegovy in Ireland Facility | Novo Nordisk to Manufacture Wegovy in Ireland Facility | [Link](https://longbridge.com/en/news/275789396.md) |
| Savvy Advisors Inc. Purchases 22,138 Shares of Novo Nordisk A/S $NVO | Savvy Advisors Inc. increased its stake in Novo Nordisk A/S by 83.0% in Q3, acquiring 22,138 shares, bringing its total  | [Link](https://longbridge.com/en/news/275761183.md) |
| Novo Nordisk Aims To Start Selling Its Weight-Loss Blockbuster Wegovy In Vials - Bloomberg News | NOVO NORDISK AIMS TO START SELLING ITS WEIGHT-LOSS BLOCKBUSTER WEGOVY IN VIALS - BLOOMBERG NEWS | [Link](https://longbridge.com/en/news/275654518.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.